10-hydroxycarbamazepine has been researched along with Aura in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.00) | 18.7374 |
1990's | 9 (36.00) | 18.2507 |
2000's | 10 (40.00) | 29.6817 |
2010's | 2 (8.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Dai, Q; Guan, Y; Huang, M; Li, R; Ren, R; Tang, S; Wang, X; Wen, D; Zhang, X; Zhou, L; Zhou, S | 1 |
Chen, X; Fang, S; Gong, Z; Ma, H; Qian, L; Wei, J; Xu, Z; Yan, Y; Yang, X; Zeng, S | 1 |
Cai, LX; Chen, CY; Cui, YM; Li, RR; Ma, LY; Sheng, XY; Wu, Y; Yao, HX; Zhou, Y; Zhu, SN | 1 |
Bartoli, A; Galimberti, CA; Gatti, G; Limido, G; Manni, R; Morini, R; Perucca, E; Strada, G; Tartara, A | 1 |
Baumann, RJ; DeGrauw, TJ; Fakhoury, TA; Grim, SA; Miles, MV; Ryan, MA; Strawsburg, RH; Tang, PH | 1 |
Clinckers, R; Ebinger, G; Meurs, A; Michotte, Y; Smolders, I | 1 |
Baumgartner, C; Caccia, S; Czech, T; Guiso, G; Janigro, D; Marchi, N; Novak, K; Pirker, S; Rizzi, M; Vezzani, A | 1 |
Bilo, L; Di Nocera, P; Fasiello, C; Italiano, D; Pisani, F; Ruosi, P; Striano, P; Striano, S | 1 |
Christensen, J; Sabers, A; Sidenius, P | 1 |
Hansen, SH; Linnet, K; Sabers, A; Simonsen, KW; Steentoft, A | 1 |
Artesi, C; Di Perri, R; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Xiao, B | 1 |
Meinardi, H; Van Parys, JA | 1 |
Schwabe, S | 1 |
Perucca, E | 1 |
May, TW; Rambeck, B; Sälke-Kellermann, A | 1 |
Frey, HH; Schicht, S; Wigger, D | 1 |
Bialer, M; Volosov, A; Yagen, B | 1 |
Christensen, J; Dam, M; Højskov, CS; Poulsen, JH | 1 |
Jouppila, P; Myllynen, P; Pienimäki, P; Vähäkangas, K | 1 |
Boas, J; Dam, M; Flesch, G; Jensen, PK; Jórgensen, L; Mogensen, PH; Vesterager, A | 1 |
Elyas, AA; Goldberg, VD; Patsalos, PN | 1 |
Paar, WD; von Unruh, GE | 1 |
Bayraktar, E; Eltokhi, A; Hedrich, UBS; Lauxmann, S; Lerche, H; Liu, Y; Lyu, H; Sara, Y; Sonnenberg, L; Wuttke, TV | 1 |
Bak, LK; Jakobsen, E; Krarup, S; Lindholm, SEH; Mertz, C; Pinborg, LH | 1 |
Albani, F; Balboni, M; Baruzzi, A; Callegati, E; Candela, C; Contin, M; Riva, R | 1 |
1 review(s) available for 10-hydroxycarbamazepine and Aura
Article | Year |
---|---|
Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Biological Availability; Carbamazepine; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Therapy, Combination; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Half-Life; Humans; Lamotrigine; Phenylcarbamates; Propylene Glycols; Topiramate; Triazines; Vigabatrin | 1996 |
4 trial(s) available for 10-hydroxycarbamazepine and Aura
Article | Year |
---|---|
Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
Topics: Adolescent; Anticonvulsants; Asian People; Carbamazepine; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Epilepsy; Female; Humans; Infant; Linear Models; Male; Oxcarbazepine; Prospective Studies; Saliva | 2016 |
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Female; Half-Life; Humans; Male; Oxcarbazepine; Phenobarbital; Valproic Acid | 1993 |
Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Epilepsies, Partial; Epilepsy; Epilepsy, Complex Partial; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Oxcarbazepine; Viloxazine | 1994 |
Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
Topics: Anticonvulsants; Biological Availability; Carbamazepine; Clinical Trials as Topic; Epilepsy; Gas Chromatography-Mass Spectrometry; Humans; Oxcarbazepine | 1986 |
20 other study(ies) available for 10-hydroxycarbamazepine and Aura
Article | Year |
---|---|
LC-MS/MS quantification of levetiracetam, lamotrigine and 10-hydroxycarbazepine in TDM of epileptic patients.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Epilepsy; Humans; Lamotrigine; Levetiracetam; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |
Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily B; Body Mass Index; Carbamazepine; Child; Child, Preschool; China; Epilepsy; Female; Genotype; Glucuronosyltransferase; Humans; Infant; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; NAV1.2 Voltage-Gated Sodium Channel; Oxcarbazepine; Polymorphism, Single Nucleotide; Young Adult | 2019 |
Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Feasibility Studies; Female; Humans; Male; Middle Aged; Oxcarbazepine; Saliva | 2004 |
Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Topics: Animals; Anticonvulsants; Biomarkers; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; Epilepsy; Hippocampus; Kinetics; Male; Metabolic Clearance Rate; Microdialysis; Pharmacokinetics; Rats; Rats, Wistar; Serotonin; Treatment Outcome | 2005 |
A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
Topics: Adult; Aged; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Carbamazepine; Child; Drug Resistance; Drug Resistance, Multiple; Epilepsy; Female; Humans; In Vitro Techniques; Male; Oxcarbazepine; Pilot Projects; RNA, Messenger | 2005 |
Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine | 2006 |
Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
Topics: Analysis of Variance; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Osmolar Concentration; Oxcarbazepine; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies | 2006 |
An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Liver; Male; Middle Aged; Muscle, Skeletal; Oxcarbazepine; Vitreous Body | 2008 |
Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Male; Middle Aged; Netherlands; Oxcarbazepine; Product Surveillance, Postmarketing; Treatment Outcome | 1994 |
Oxcarbazepine: clinical development program.
Topics: Aged; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Approval; Drugs, Investigational; Enzyme Induction; Epilepsy; Humans; Liver; Oxcarbazepine; United States; United States Food and Drug Administration | 1994 |
Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Humans; Middle Aged; Time Factors; Valproic Acid | 1996 |
Pharmacokinetics of oxcarbazepine in the dog.
Topics: Administration, Oral; Animals; Anticonvulsants; Blood Proteins; Carbamazepine; Dogs; Epilepsy; Female; Half-Life; Jejunum; Male; Oxcarbazepine; Protein Binding; Statistics as Topic | 1996 |
Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Carbamazepine; Cross-Over Studies; Dogs; Drug Design; Epilepsy; Glucuronides; Humans; Oxcarbazepine; Stereoisomerism | 2000 |
Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.
Topics: Adolescent; Adult; Anticonvulsants; Blood-Brain Barrier; Brain; Carbamazepine; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans; Lamotrigine; Male; Middle Aged; Oxcarbazepine; Prospective Studies; Topiramate; Triazines | 2001 |
Transplacental passage of oxcarbazepine and its metabolites in vivo.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Oxcarbazepine; Placenta; Pregnancy; Pregnancy Complications | 2001 |
Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dextropropoxyphene; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine; Trigeminal Neuralgia | 1992 |
Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine.
Topics: Autoanalysis; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Microchemistry; Oxcarbazepine | 1990 |
In vitro effects of eslicarbazepine (S-licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.
Topics: Animals; Dibenzazepines; Epilepsy; Mice; Mutation; NAV1.6 Voltage-Gated Sodium Channel | 2023 |
Distinct effects on cAMP signaling of carbamazepine and its structural derivatives do not correlate with their clinical efficacy in epilepsy.
Topics: Adenylyl Cyclases; Anticonvulsants; Calcium Signaling; Carbamazepine; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dibenzazepines; Epilepsy; HEK293 Cells; Humans; Oxcarbazepine; Seizures; Signal Transduction; Treatment Outcome | 2020 |
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dibenzazepines; Drug Monitoring; Epilepsy; Felbamate; Humans; Lamotrigine; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Spectrophotometry, Ultraviolet; Triazines | 2005 |